Rachel Darwin, Senior Manager, Public Relations
Researchers found that patients with cancer who receive nursing-led palliative care are more likely to engage in advance care planning, which in turn may make them feel more supported in decision-making.
PLYMOUTH MEETING, PA [April 4, 2023] — New research in the April 2023 issue of JNCCN—Journal of the National Comprehensive Cancer Network finds that specially trained oncology infusion room nurses can improve advance care planning (ACP) for patients with advanced cancer. In this study, oncology nurses underwent an immersive, three-day training session on palliative care. As compared to patients who received standard care, those who participated in this targeted and specialized intervention had a dramatically increased rate of creating advance directives and taking part in conversation about end-of-life issues. Of the people included who had not previously had an end-of-life conversation, 45.1% of patients who engaged with these trained nurses within this program subsequently engaged in conversations about end-of-life care within three months, compared to just 14.8% who underwent standard care. The numbers were similar (43.2% and 18.1%, respectively) for those who completed an advance directive, also known as a living will.
“I was surprised to see that this approach to primary palliative care increased uptake of advance care planning so significantly, particularly because the oncology nurses told us that this was one of the hardest things we asked them to do. Clearly, they rose to the challenge and were able to have a major impact on rates of ACP,” said Yael Schenker, MD, MAS, FAAHPM, director of the Palliative Research Center and professor in the Division of General Internal Medicine, University of Pittsburgh and UPMC. “Advance care planning is a process designed to help people have a voice in their medical care. For people with serious illness like advanced cancer, this kind of communication can allay anxiety, help patients and families to feel more supported in decision making, and help to ensure that people receive the kind of care that aligns with their preferences.”
The randomized trial involved 672 patients across 17 community clinics in Western Pennsylvania from July 2016 through October 2019. All enrolled patients had advanced solid tumor malignancies and an indication from their doctor that end-of-life would not be surprising within a year. The patients completed a survey on ACP at the time of enrollment, and again three months later. 378 did not initially report having had an end-of-life conversation and 216 lacked an advance directive at the time of enrollment.
The palliative care training for the nurses focused on four key areas:
“Advance care planning is an important component of care for patients with advanced cancers,” continued Dr. Schenker. “Empowering and training nurses to develop shared care plans with patients and communicate this with oncologists represents a unique and effective way to improve advance care planning in this population. Leadership support and protected time are needed to ensure that nurses are able to accomplish non-treatment-related activities like advance care planning.”
“Advance care planning is critical to providing high-quality care to patients with cancer and is highlighted in the NCCN Guidelines for Palliative Care,” commented Anne M. Walling, MD, PhD, FAAHPM, Associate Professor of Medicine; Director of Palliative Care Research; Department of Medicine, UCLA and Member of the UCLA Jonsson Comprehensive Cancer Center, who was not involved in this research.
Dr. Walling—who was recently named Chair of the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Panel for Palliative Care—continued: “These study results provide evidence to support oncology nurses playing a key role in this important care process.”
To read the entire study, visit JNCCN.org. Complimentary access to “Primary Palliative Care Improves Uptake of Advance Care Planning Among Patients With Advanced Cancers” is available until July 10, 2023.
# # #
About JNCCN—Journal of the National Comprehensive Cancer Network
More than 25,000 oncologists and other cancer care professionals across the United States read JNCCN—Journal of the National Comprehensive Cancer Network. This peer-reviewed, indexed medical journal provides the latest information about innovation in translational medicine, and scientific studies related to oncology health services research, including quality care and value, bioethics, comparative and cost effectiveness, public policy, and interventional research on supportive care and survivorship. JNCCN features updates on the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®), review articles elaborating on guidelines recommendations, health services research, and case reports highlighting molecular insights in patient care. JNCCN is published by Harborside. Visit JNCCN.org. To inquire if you are eligible for a FREE subscription to JNCCN, visit NCCN.org/jnccn/subscribe. Follow JNCCN on Twitter @JNCCN.
About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network® (NCCN®) is a not-for-profit alliance of leading cancer centers devoted to patient care, research, and education. NCCN is dedicated to improving and facilitating quality, effective, equitable, and accessible cancer care so all patients can live better lives. The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) provide transparent, evidence-based, expert consensus recommendations for cancer treatment, prevention, and supportive services; they are the recognized standard for clinical direction and policy in cancer management and the most thorough and frequently-updated clinical practice guidelines available in any area of medicine. The NCCN Guidelines for Patients® provide expert cancer treatment information to inform and empower patients and caregivers, through support from the NCCN Foundation®. NCCN also advances continuing education, global initiatives, policy, and research collaboration and publication in oncology. Visit NCCN.org for more information.